Publication Date:
1983-01-28
Description:
The benzodiazepine receptor antagonist 3-hydroxymethyl-beta-carboline, which blocks several of the pharmacological actions of benzodiazepines, induces a dose-dependent increase in sleep latency in the rat. Furthermore, at a low dose that by itself does not affect sleep, 3-hydroxymethyl-beta-carboline blocks sleep induction by a large dose of flurazepam. The benzodiazepine receptor may play a role in both the physiological regulation and pharmacological induction of sleep.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Mendelson, W B -- Cain, M -- Cook, J M -- Paul, S M -- Skolnick, P -- New York, N.Y. -- Science. 1983 Jan 28;219(4583):414-6.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/6294835" target="_blank"〉PubMed〈/a〉
Keywords:
Animals
;
Carbolines/*pharmacology
;
Flurazepam/*antagonists & inhibitors
;
Indoles/*pharmacology
;
Male
;
Rats
;
Receptors, Cell Surface/*drug effects
;
Receptors, GABA-A
;
Sleep/*drug effects
;
Wakefulness/drug effects
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink
